Gateway to Think Tanks
来源类型 | Working Paper |
规范类型 | 报告 |
DOI | 10.3386/w17249 |
来源ID | Working Paper 17249 |
China and India as Suppliers of Affordable Medicines to Developing Countries | |
Tamara Hafner; David Popp | |
发表日期 | 2011-07-28 |
出版年 | 2011 |
语种 | 英语 |
摘要 | As countries reform their patent laws to be in compliance with the Trade Related Intellectual Property Rights Agreement, an important question is how increased patent protection will affect drug prices in low-income countries. Using pharmaceutical trade data from 1996 to 2005, we examine the role of China and India as suppliers of medicines to other middle- and low-income countries and evaluate the competitive effect of medicine imports from these countries on the price of medicines from high- income countries. We find that imports of antibiotics and unspecified medicaments from India and China significantly depress the average price of these commodities imported from high-income trading partners, suggesting that India and China are not only important sources of inexpensive medicines but also have an indirect effect by lowering prices through competition. As India is the leading supplier of medicines in Sub-Saharan Africa, this region will likely be affected most adversely. |
主题 | Health, Education, and Welfare ; Health ; Development and Growth ; Development ; Innovation and R& ; D |
URL | https://www.nber.org/papers/w17249 |
来源智库 | National Bureau of Economic Research (United States) |
引用统计 | |
资源类型 | 智库出版物 |
条目标识符 | http://119.78.100.153/handle/2XGU8XDN/574924 |
推荐引用方式 GB/T 7714 | Tamara Hafner,David Popp. China and India as Suppliers of Affordable Medicines to Developing Countries. 2011. |
条目包含的文件 | ||||||
文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
w17249.pdf(423KB) | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[Tamara Hafner]的文章 |
[David Popp]的文章 |
百度学术 |
百度学术中相似的文章 |
[Tamara Hafner]的文章 |
[David Popp]的文章 |
必应学术 |
必应学术中相似的文章 |
[Tamara Hafner]的文章 |
[David Popp]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。